Lumos Pharma, Inc. (LUMO)

Lumos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12	25	30	58	296	94
Market Cap Growth	-15.97%	-16.77%	-47.79%	-80.45%	213.85%	66.85%
Enterprise Value	-11	-10	-37	-36	198	90
PE Ratio	-	-0.74	-0.97	-1.90	-46.93	-7.41
PS Ratio	7.77	12.27	19.85	251.81	1763.62	-
PB Ratio	0.68	0.92	0.51	0.65	2.54	-1.59
P/FCF Ratio	-0.66	-0.81	-1.13	-1.95	31.28	-10.38
P/OCF Ratio	-0.66	-0.81	-1.14	-1.95	-12.88	-10.39
EV/Sales Ratio	0.13	-5.03	-24.22	-157.98	1178.14	-
EV/EBITDA Ratio	-0.01	0.30	1.19	1.18	-10.39	-9.29
EV/EBIT Ratio	-0.01	0.30	1.19	1.17	-10.08	-9.26
EV/FCF Ratio	-0.01	0.33	1.38	1.22	20.89	-9.88
Debt / Equity Ratio	0.03	0.02	0.00	0.01	0.00	-0.01
Debt / EBITDA Ratio	-0.01	-0.02	-0.01	-0.02	-0.02	-0.04
Debt / FCF Ratio	-0.01	-0.02	-0.01	-0.02	0.03	-0.04
Quick Ratio	5.29	5.16	10.07	18.51	19.32	3.95
Current Ratio	6.24	5.70	10.74	19.43	19.88	4.01
Asset Turnover	0.04	0.04	0.02	0.00	0.00	0
Return on Equity (ROE)	-119.90%	-85.60%	-43.80%	-31.00%	-5.30%	-21.90%
Return on Assets (ROA)	-85.90%	-65.30%	-37.60%	-27.60%	-4.10%	-14.10%
Return on Capital (ROIC)	-219.64%	-131.28%	-53.56%	-35.01%	-22.50%	16.61%
Earnings Yield	-313.32%	-135.23%	-102.72%	-52.54%	-2.13%	-13.50%
FCF Yield	-293.60%	-123.55%	-88.11%	-51.24%	3.20%	-9.63%
Buyback Yield / Dilution	1.64%	2.73%	-0.47%	-22.97%	-420.42%	68.48%
Total Shareholder Return	1.64%	2.73%	-0.47%	-22.97%	-420.42%	68.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).